We are live on ! Find out more
VNRX icon

VolitionRx Ltd

28 hedge funds and large institutions have $4.13M invested in VolitionRx Ltd in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

0.56% less ownership

Funds ownership: 1.21%0.66% (-0.56%)

15% less funds holding

Funds holding: 3328 (-5)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

77% less capital invested

Capital invested by funds: $17.7M → $4.13M (-$13.6M)

Holders
28
Holders Change
-5
Holders Change %
-15.15%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
9
Reduced
7
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
$79 -$5.51K -725 -98%
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
$68
SS
28
SBI Securities
Japan
$30
AC
29
Armistice Capital
New York
-$6.37M -469,021 Closed
XT
30
XTX Topco
Cayman Islands
-$24.2K -1,784 Closed
Millennium Management
31
Millennium Management
New York
-$19.9K -1,468 Closed
HF
32
HRT Financial
New York
-$11K -828 Closed
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
-$4K -330 Closed
AAS
34
Ameritas Advisory Services
Nebraska
-$2.71K -200 Closed
FCMT
35
Founders Capital Management (Texas)
Texas
-$1.36K -100 Closed
Fidelity Investments
36
Fidelity Investments
Massachusetts
-$475 -35 Closed
Citigroup
37
Citigroup
New York
-$236 -17 Closed
AF
38
Allworth Financial
California
-$136 -10 Closed

VNRX Hedge Fund Activity: Q4 2025 in Review

28 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2025, worth a combined $4.13M — down 77% from $17.7M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of VNRX and 6 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 9 added.

The largest buyer was Squarepoint, opening a new position worth an estimated $51.1K. The largest seller was Armistice Capital, exiting entirely with an estimated $6.37M sold.

  • 28 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2025, down from 33 in Q3 2025.
  • Funds reported $4.13M of VolitionRx Ltd stock for Q4 2025, down 77% quarter-over-quarter.
  • 6 funds opened new VolitionRx Ltd positions in Q4 2025 and 11 closed out, a net change of -5 holders.
  • The largest VolitionRx Ltd buyer in Q4 2025 was Squarepoint, an estimated $51.1K added.
  • The largest VolitionRx Ltd seller in Q4 2025 was Armistice Capital, an estimated $6.37M sold.

Based on aggregated 13F filings for Q4 2025.